BRIEF published on 07/24/2025 at 14:16, 9 months 11 days ago FUTRUE GmbH Proposes Squeeze-Out for PharmaSGP Minority Shareholders Shareholders Compensation Squeeze-out PharmaSGP Futrue GmbH
PRESS RELEASE published on 07/24/2025 at 14:11, 9 months 11 days ago EQS-Adhoc: FUTRUE GmbH submits request to implement squeeze-out of minority shareholders of PharmaSGP Holding SE FUTRUE GmbH requests squeeze-out of minority shareholders by PharmaSGP Holding SE as it holds over 95% shares. Valuation ongoing for cash compensation determination Squeeze-out Minority Shareholders Cash Compensation PharmaSGP Holding SE Futrue GmbH
BRIEF published on 07/18/2025 at 12:02, 9 months 17 days ago PharmaSGP Holding SE Announces Delisting Offer by FUTRUE GmbH Shareholders Healthcare Products Delisting Offer PharmaSGP Futrue GmbH
PRESS RELEASE published on 07/18/2025 at 11:57, 9 months 17 days ago PharmaSGP Holding SE: Acceptance period for FUTRUE GmbH’s public delisting tender offer underway PharmaSGP Holding SE announces FUTRUE GmbH's public delisting tender offer acceptance period. Shareholders can tender shares for €28.00 cash consideration until August 11, 2025 Shareholders Tender Offer Delisting Cash Consideration PharmaSGP Holding SE
BRIEF published on 07/11/2025 at 08:06, 9 months 24 days ago PharmaSGP Holding SE Revises 2025 Revenue Forecast Adjusted EBITDA Revenue Adjustment PharmaSGP 2025 Forecast Geopolitical Uncertainty
PRESS RELEASE published on 07/11/2025 at 08:01, 9 months 24 days ago EQS-Adhoc: PharmaSGP Holding SE adjusts its revenues forecast for the full year 2025 PharmaSGP Holding SE adjusts full year 2025 revenue forecast due to current data evaluation. Adjusted forecast now €132.0-138.0 million. EBITDA expectation maintained EBITDA Revenue Forecast PharmaSGP Holding SE Adjusted Forecast 2025 Fiscal Year
BRIEF published on 06/26/2025 at 12:44, 10 months 8 days ago PharmaSGP Holding SE Holds Annual General Meeting 2025 Financial Results Dividend Policy Annual Meeting PharmaSGP 2025 Forecast
PRESS RELEASE published on 06/26/2025 at 12:39, 10 months 8 days ago PharmaSGP Holding SE holds 2025 Annual General Meeting PharmaSGP Holding SE reports on 2025 Annual General Meeting, with 91.12% share capital represented, €0.05 dividend per share approved, and confirmation of 2025 fiscal year forecast Annual General Meeting Dividend Forecast PharmaSGP Holding SE OTC Pharmaceuticals
BRIEF published on 06/18/2025 at 17:34, 10 months 16 days ago PharmaSGP SE to Redeem Shares Amid Upcoming Delisting Treasury Shares Delisting Squeeze-out Share Redemption PharmaSGP
PRESS RELEASE published on 06/18/2025 at 17:29, 10 months 16 days ago PharmaSGP SE plans to redeem own shares – conditions for squeeze-out under conversion law are met PharmaSGP SE plans to redeem treasury shares to optimize use of new authorization, leading to a squeeze-out possibility due to increased ownership percentage Share Buyback Treasury Shares Squeeze-out PharmaSGP Conversion Law
Published on 05/05/2026 at 01:59, 2 hours 42 minutes ago Tolmer Yields >100,000 g/t Silver Trial Gravity Concentrate
Published on 05/04/2026 at 23:55, 4 hours 46 minutes ago Avant Brands Announces Voting Results from Its 2026 Annual General and Special Meeting of Shareholders
Published on 05/04/2026 at 23:01, 5 hours 40 minutes ago Copper Road Announces Closing of Non-Brokered Private Placement
Published on 05/04/2026 at 23:00, 5 hours 41 minutes ago PJX Resources Adopting Semi-Annual Financial Reporting ("SAR")
Published on 05/04/2026 at 22:50, 5 hours 51 minutes ago IBC Advanced Alloys Announces Amendment of Existing Credit Facility
Published on 05/05/2026 at 02:42, 1 hour 59 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus secures strategic partnership with Boral to deliver one of Australia’s largest logistics precincts
Published on 05/05/2026 at 02:34, 2 hours 7 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: March 2026 quarter update and Macquarie Australia Conference Presentation
Published on 05/04/2026 at 21:05, 7 hours 36 minutes ago EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for Q1 2026 of €47.9 million and adjusted EBITDA of €7.6 million; forecast for the continuing operations unchanged
Published on 05/04/2026 at 20:02, 8 hours 39 minutes ago EQS-Adhoc: Rheinmetall AG: Preliminary operating margin in line with market expectation; revenue below market expectation despite growth due to delays into Q2 – 2026 full-year forecast reaffirmed
Published on 05/04/2026 at 19:30, 9 hours 11 minutes ago Shareholders approve all proposals – Dr Annelise Lüscher Hämmerli and Urs Simeon elected to the Board of Directors
Published on 05/04/2026 at 20:57, 7 hours 44 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 05/04/2026 at 17:59, 10 hours 42 minutes ago Saint-Gobain has signed an agreement for the sale of its distribution business in Brazil
Published on 05/04/2026 at 17:38, 11 hours 3 minutes ago Reporting on share buyback transactions carried out between April 29 and April 30, 2026
